COL12A1 is aberrantly upregulated in human malignancies including gastric cancer, colon cancer, colorectal cancer and pancreatic adenocarcinoma, and its upregulation correlated with tumor progression and poor prognosis [15–18]. This evidence concerns the gene COL12A1 and neoplasm.